Is Vinay Prasad’s departure from the FDA beneficial for the biotech sector?
Understanding the Impact of Vinay Prasad’s Departure from the FDA Key Takeaways: Vinay Prasad’s exit from the FDA has sparked mixed reactions. His approach to cell and gene therapies was seen as overly cautious. Many in biotech view his ouster as potentially beneficial for innovation. Reactions are tied to broader concerns about regulatory balance. The …